Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX
· Real-Time Price · USD
0.77
0.03 (4.58%)
At close: Aug 15, 2025, 11:00 AM
Context Therapeutics Fail-to-Deliver
Total FTD Shares
946.19K
Above Average
FTD / Avg. Volume
399.70%
High Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jun 12, 2025,
Context Therapeutics Inc. has
946,186
shares failed to deliver, representing 399.70%
of the average daily volume of
236,725
shares. Over the past year, the monthly average FTD is
24,356
shares, with the current level 3785% above
the historical average, indicating
elevated
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 12, 2025 | 0.6526 | 946.19K | +33596.08% |
| May 21, 2025 | 0.691 | 2.81K | -89.84% |
| Apr 25, 2025 | 0.94 | 27.64K | +11044.76% |
| Mar 27, 2025 | 0.7365 | 248 | -95.69% |
| Feb 24, 2025 | 0.8314 | 5.75K | -99.16% |
| Jan 02, 2025 | 1.19 | 682.29K | +11960.99% |
| Dec 26, 2024 | 1.14 | 5.66K | +548.00% |
| Nov 26, 2024 | 1.47 | 873 | -6.33% |
| Oct 29, 2024 | 2.24 | 932 | -53.49% |
| Sep 23, 2024 | 2.08 | 2K | +378.28% |
| Aug 29, 2024 | 2.45 | 419 | -40.74% |
| Jul 31, 2024 | 2.16 | 707 | -98.04% |
| Jun 27, 2024 | 2.01 | 36.05K | +64275.00% |
| May 29, 2024 | 2 | 56 | -66.86% |
| Apr 23, 2024 | 1.41 | 169 | +267.39% |
| Mar 26, 2024 | 1.27 | 46 | -47.73% |
| Feb 26, 2024 | 1.13 | 88 | -5.38% |
| Jan 30, 2024 | 1.06 | 93 | -97.43% |
| Dec 29, 2023 | 1.13 | 3.62K | +224.22% |
| Nov 21, 2023 | 0.81 | 1.11K | +27.43% |
| Oct 24, 2023 | 1.25 | 875 | -78.46% |
| Sep 29, 2023 | 1.51 | 4.06K | +1157.89% |
| Aug 03, 2023 | 1.24 | 323 | +83.52% |
| Jul 12, 2023 | 1.36 | 176 | -96.38% |
| Jun 29, 2023 | 1.39 | 4.86K | +985.04% |
| May 31, 2023 | 0.87 | 448 | -61.51% |
| Apr 28, 2023 | 0.581 | 1.16K | -59.20% |
| Mar 31, 2023 | 0.562 | 2.85K | -58.95% |
| Feb 28, 2023 | 0.77 | 6.95K | +4864.29% |
| Jan 26, 2023 | 0.7267 | 140 | n/a |